Mylan Market Cap 2006-2019 | MYL
Mylan market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Mylan market cap as of January 21, 2020 is $11.17B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $11.174B | $11.434B |
| Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allergan (AGN) | Ireland | $63.220B | 11.52 |
| Teva Pharmaceutical Industries (TEVA) | Israel | $10.943B | 4.45 |
| Bausch Health Cos (BHC) | Canada | $10.478B | 6.91 |
| Dr Reddy's Laboratories (RDY) | India | $7.056B | 18.51 |
| ASPEN PHARMACR (APNHY) | South Africa | $3.747B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $1.295B | 12.53 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.938B | 48.76 |
| Homology Medicines (FIXX) | United States | $0.726B | 0.00 |
| Mallinckrodt Public (MNK) | United Kingdom | $0.508B | 0.69 |
| Voyager Therapeutics (VYGR) | United States | $0.496B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.457B | 0.00 |
| Progenics Pharmaceuticals (PGNX) | United States | $0.401B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.254B | 0.00 |
| Adamas Pharmaceuticals (ADMS) | United States | $0.166B | 0.00 |
| Akorn (AKRX) | United States | $0.165B | 0.00 |
| CymaBay Therapeutics (CBAY) | United States | $0.134B | 0.00 |
| Zynerba Pharmaceuticals (ZYNE) | United States | $0.132B | 0.00 |
| Teligent (TLGT) | United States | $0.021B | 0.00 |
| China Pharma Holdings (CPHI) | China | $0.018B | 0.00 |
